‘What is health?’ and KHN: News Maybe you are


Can’t find the microphone? Click here to listen to Acast. You can listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts.


Health policy is more stringent these days, so the council’s recess gave time to explore some of the most important stories that people haven’t missed, according to the decision and Medicare will severely limit the coverage of Aduhelm, the new controversial drug to treat Alzheimer’s disease. And even with Congress leaving, states are rushing to restrict or increase access to deregulation, ahead of a much -anticipated Congressional decision later this spring to summer. .

This week’s panelists include Julie Rovner of KHN, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, and Alice Miranda Ollstein of Politico.

Among the excerpts from this week’s article:

  • The decision by the Centers for Medicare & Medicaid Services to limit Medicare coverage to Aduhelm only to beneficiaries who are also enrolling in new Alzheimer’s drug clinical trials came despite strong demands by patients and support groups are frustrated by the lack of new treatments for this. malignant disease. But the federal government has been plagued by controversy by some researchers and health professionals about the flaws of prior research into medicine.
  • The dirt on Medicare coverage for Aduhelm points to a source of controversy over the U.S. health system: Other government agencies are covered by the authorities. This controversy is between the FDA, which approves the drug despite serious questions about its efficacy and safety, and CMS, which decides whether to cover the cost of a disputed drug. very much. But different arguments have been played out between the FDA and the Centers for Disease Control and Prevention over covid-19 disease control and efficacy.
  • A recent Bloomberg report highlighted concerns that the federal government is paying too much for benefits enrolled in Medicare Advantage programs. Progressive Democrats in Congress have long complained about this, but Republicans are strong supporters of the Medicare Advantage program.
  • While some people on the left are complaining about the excessive cost of these Medicare plans, they are growing. That is, in part, because there are so many opportunities and sharing benefits of the traditional Medicare program that people with low incomes are worried about the shoulder, and Medicare Advantage has been lost. to interest them. This made it difficult for the first partisan politics to be on the agenda.
  • Biden’s leadership was reportedly in talks with several states about setting up programs to import soft drugs from Canada. For Democrats, this could be a powerful motivational conversation – like the efforts on Capitol Hill to keep the price of insulin down – about trying to help people with a pocketbook problem. serious. The price of the drug is what worries consumers.
  • However, it is not clear if Canada wants to help the U.S. with a drug import program, and if it does, there is no evidence that it could significantly change the amount of drugs available to the U.S. the Canadians supply the prices in this country.
  • The Oklahoma governor signed the bill to make it a felony to practice abortion, and the Florida governor approved Thursday a bill removing the limit for abortion from 24 weeks to 15 weeks. week. The country is waiting for the Supreme Court to decide a case this summer that could overthrow or weaken the nation. Roe v. Wade As a result, conservative states are moving to find ways to limit or prohibit detention.
  • If the Supreme Court removes the barriers laid down under Roe conclusion, it may not be possible for medical clinics in states that care for the need to die to fill the need.
  • However with the growing movement in conservative states, abortion-rights advocates were shocked this week when a Texas prosecutor filed murder charges against an arrested woman. The complaints were immediately dismissed.
  • The CDC released new data this week showing an increase by 2020 in the number of cases of gonorrhea and syphilis – which may be the result of lower access to gonorrhea and syphilis. health care in the early stages of the disease. While antibiotics can be easily cured, the general public is unaware of the need to seek medical attention or the harmful consequences of leaving patients untreated.
  • The CDC also reported that the number of drug deaths reached last year.

In addition, for additional credit, the panelists share their favorite health policy story of the week that they hope others will read as well:

Julie Rovner: Politico’s “Mice Occupy FDA Offices After Food Left Behind in Pandemic,” by David Lim and Lauren Gardner

About Margot Sanger-Katz: ‘Health Sciences’ “Most Medicare recipients do not complete high -quality medical prescription forms,” by Stacie B. Dusetzina et al. al

Joanne Kenen: Vox’s “America Needs Doctors and Nurses to Survive New Disease,” by Dylan Scott

Alice Miranda Ollstein: Politico’s “Republicans See CDC’s Policy Change as ‘Massive Political Loser for Democrats,'” by Alice Miranda Ollstein and Krista Mahr

Also discussed in this week’s podcast:

Bloomberg “Major providers are cheating billions from Medicare, says Whistle-Blowers,” by John Tozzi

“Research: Medicare Advantage Plans Pay Billions More Than Benefits,” by Fred Schulte

KHN’s “‘What the Health?’: The Drug Price Dilemma,” featuring Stacie B. Dusetzina


To listen to our full podcasts, click here.

And subscribe to KHN’s What the Health? on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts.

Related topics

Contact us Submit a story comment

Related Posts

Leave a Reply

Your email address will not be published.